Causes of gastrointestinal bleeding in oral anticoagulant users compared to non-users in a population-based study

References

• Loperfido S, Baldo V, Piovesana E, et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc. 2009;70(2):212–224.
   PubMed Web of Science ®Google Scholar
• Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ. 1995;311(6999):222–226.
   PubMedGoogle Scholar
• Paspatis GA, Konstantinidis K, Chalkiadakis I, et al. Changing trends in acute upper gastrointestinal bleeding in Crete, Greece: a population-based study. Eur J Gastroenterol Hepatol. 2012;24(1):102–103.
   PubMed Web of Science ®Google Scholar
• Hreinsson JP, Kalaitzakis E, Gudmundsson S, et al. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol. 2013;48(4):439–447.
   PubMed Web of Science ®Google Scholar
• Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 1997;92(3):419–424.
   PubMed Web of Science ®Google Scholar
• Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104(7):1633–1641.
   PubMed Web of Science ®Google Scholar
• Ahsberg K, Hoglund P, Kim WH, et al. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding. Scand J Gastroenterol. 2010;45(12):1404–1415.
   PubMed Web of Science ®Google Scholar
• Hreinsson JP, Gumundsson S, Kalaitzakis E, et al. Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. Eur J Gastroenterol Hepatol. 2013;25(1):37–43.
   PubMed Web of Science ®Google Scholar
• Patel PA, Zhao X, Fonarow GC, et al. Novel oral anticoagulant use among patients with atrial fibrillation hospitalized with ischemic stroke or transient ischemic attack. Circ Cardiovasc Qual Outcomes. 2015;8(4):383–392.
   PubMed Web of Science ®Google Scholar
• Elewa H, Alhaddad A, Al-Rawi S, et al. Trends in oral anticoagulant use in Qatar: a 5-year experience. J Thromb Thrombolysis. 2017;43(3):411–416.
   PubMed Web of Science ®Google Scholar
• Kjerpeseth LJ, Ellekjaer H, Selmer R, et al. Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015. Eur J Clin Pharmacol. 2017;73(11):1417–1425.
   PubMed Web of Science ®Google Scholar
• Weitz JI, Semchuk W, Turpie AG, et al. Trends in prescribing oral anticoagulants in Canada, 2008–2014. Clin Ther. 2015;37(11):2506–2514 e4.
   PubMed Web of Science ®Google Scholar
• Marzec LN, Wang J, Shah ND, et al. Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2017;69(20):2475–2484.
   PubMed Web of Science ®Google Scholar
• Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–953.
   PubMed Web of Science ®Google Scholar
• Salomon JA, Wang H, Freeman MK, et al. Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012;380(9859):2144–2162.
   PubMed Web of Science ®Google Scholar
• Kobbervig CE, Heit JA, Petterson TM, et al. The effect of patient age and calendar year on the incidence of idiopathic vs. secondary venous thromboembolism (VTE): a population-based cohort study. Blood. 2004;104(11):3516–351a.
   Web of Science ®Google Scholar
• White RH, Zhou H, Gage BF. Effect of age on the incidence of venous thromboembolism after major surgery. J Thromb Haemost. 2004;2(8):1327–1333.
   PubMed Web of Science ®Google Scholar
• Hreinsson JP, Jonsson A, Bjornsson ES. Acute upper gastrointestinal bleeding: a population-based, five-year follow-up study. Scand J Gastroenterol. 2021;56(1):1–5.
   PubMed Web of Science ®Google Scholar
• Hreinsson JP, Palsdottir S, Bjornsson ES. The association of drugs with severity and specific causes of acute lower gastrointestinal bleeding: a prospective study. J Clin Gastroenterol. 2016;50(5):408–413.
   PubMed Web of Science ®Google Scholar
• The Directorate of Health. The Prescription Medicines Register. https://www.landlaeknir.is/um-embaettid/greinar/grein/item42938/The-Prescription-Medicines-Database2020. [cited 2020 January 24]. Available from: https://www.landlaeknir.is/um-embaettid/greinar/grein/item42938/The-Prescription-Medicines-Database
   Google Scholar
• Schulman S, Kearon C. Subcommittee on control of anticoagulation of the S, standardization committee of the international society on T, haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Thygesen SK, Christiansen CF, Christensen S, et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
   PubMed Web of Science ®Google Scholar
• Ingason AB, Hreinsson JP, Ágústsson AS, et al. Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: a nationwide propensity Score-Weighted study. Ann Intern Med. 2021.
   PubMedGoogle Scholar
• Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594–642.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Rosch T, Bretthauer M. Colorectal cancer screening-optimizing current strategies and new directions. Nat Rev Clin Oncol. 2013;10(3):130–142.
   PubMed Web of Science ®Google Scholar
• Strum WB. Colorectal adenomas. N Engl J Med. 2016;374(11):1065–1075.
   PubMed Web of Science ®Google Scholar
• Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370(14):1298–1306.
   PubMed Web of Science ®Google Scholar
• Hreinsson JP, Jonasson JG, Bjornsson ES. Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study. Aliment Pharmacol Ther. 2014;39(1):77–84.
   PubMedGoogle Scholar
• Rasmussen PV, Dalgaard F, Gislason GH, et al. Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation. Eur Heart J. 2020.
   Web of Science ®Google Scholar
• Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;(3):CD000024.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295(13):1519–1530.
   PubMed Web of Science ®Google Scholar
• Tsimperidis AG, Kapsoritakis AN, Linardou IA, et al. The role of hypercoagulability in ischemic colitis. Scand J Gastroenterol. 2015;50(7):848–855.
   PubMed Web of Science ®Google Scholar
• Koutroubakis IE, Sfiridaki A, Theodoropoulou A, et al. Role of acquired and hereditary thrombotic risk factors in Colon ischemia of ambulatory patients. Gastroenterology. 2001;121(3):561–565.
   PubMed Web of Science ®Google Scholar
• Theocharis GJ, Thomopoulos KC, Sakellaropoulos G, et al. Changing trends in the epidemiology and clinical outcome of acute upper gastrointestinal bleeding in a defined geographical area in Greece. J Clin Gastroenterol. 2008;42(2):128–133.
   PubMed Web of Science ®Google Scholar
• Arroja B, Cremers I, Ramos R, et al. Acute lower gastrointestinal bleeding management in Portugal: a multicentric prospective 1-year survey. Eur J Gastroenterol Hepatol. 2011;23(4):317–322.
   PubMed Web of Science ®Google Scholar
• Gayer C, Chino A, Lucas C, et al. Acute lower gastrointestinal bleeding in 1,112 patients admitted to an urban emergency medical center. Surgery. 2009;146(4):600–606.
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Bhatt DL. Gastrointestinal bleeding with oral anticoagulation: understanding the scope of the problem. Clin Gastroenterol Hepatol. 2017;15(5):691–693.
   PubMed Web of Science ®Google Scholar
• Vajravelu RK, Mamtani R, Scott FI, et al. Incidence, risk factors, and clinical effects of recurrent diverticular hemorrhage: a large cohort study. Gastroenterology. 2018;155(5):1416–1427.
   PubMed Web of Science ®Google Scholar
• Lorenzo D, Gallois C, Lahmek P, et al. Middle-term mortality and re-bleeding after initial diverticular bleeding: a nationwide study of 365 mostly elderly french patients. United Eur Gastroenterol J. 2017;5(1):119–127.
   PubMed Web of Science ®Google Scholar
• Turpin M, Gregory P. Direct oral anticoagulant use and risk of diverticular hemorrhage: a systematic review of the literature. Can J Gastroenterol Hepatol. 2019;2019:9851307.
   PubMed Web of Science ®Google Scholar
• Groenen MJ, Kuipers EJ, Hansen BE, et al. Incidence of duodenal ulcers and gastric ulcers in a Western population: back to where it started. Can J Gastroenterol. 2009;23(9):604–608.
   PubMed Web of Science ®Google Scholar
• Ford AC, Gurusamy KS, Delaney B, et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016;4(4):CD003840.
   PubMedGoogle Scholar
• Hálfdánarson ÓÖ, Pottegård A, Björnsson ES, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol. 2018;11:1756284818777943. [Internet]. Available from: http://europepmc.org/abstract/MED/29872455 https://europepmc.org/articles/PMC5977421 https://europepmc.org/articles/PMC5977421?pdf=render
   Web of Science ®Google Scholar
• Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137(5):1776–1784.
   PubMed Web of Science ®Google Scholar
• Dunbar KB, Agoston AT, Odze RD, et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes. JAMA. 2016;315(19):2104–2112.
   PubMed Web of Science ®Google Scholar
• Zemer-Wassercug N, Haim M, Leshem-Lev D, et al. The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers. J Thromb Thrombolysis. 2015;40(3):340–346.
   PubMed Web of Science ®Google Scholar